Prevalence of Pulmonary Hypertension in Sickle Cell Anemiai Patient in KSA

被引:0
|
作者
Balbaid, Eman AbdulAziz [1 ]
Murad, Manal Abdulaziz [2 ]
Abousada, Hoda Jehad [3 ]
Banjar, Abdurrahman Yousuf [4 ]
Taj, Mashael Abdulghani [4 ]
Bamohsen, Nazeha Khalid [5 ]
Alghubishi, Somayah Ali [6 ]
Alrsheedi, Ahmed Jaza Mohson [7 ]
Alshanbari, Nada Faiez [8 ]
Alsahaqi, Raneem Siddiq Nasser [5 ]
Alharbi, Abdulmajeed Abdulaziz [9 ]
Kudam, Rana Abualqasim Mohammed [10 ]
Alanazi, Abdulmajeed Hadi [11 ]
Alharbi, Hassan Mansour [6 ]
Alsulaimi, Abdullah Matar [5 ]
机构
[1] Jeddah Univ, Med Ctr, Jeddah, Saudi Arabia
[2] King Abdulaziz Univ, Family Med Dept, Jeddah, Saudi Arabia
[3] KFH, Jeddah, Saudi Arabia
[4] UQU, Mecca, Saudi Arabia
[5] Ibn Sina Med Coll, Jeddah, Saudi Arabia
[6] UQU, Al Qunfudah, Saudi Arabia
[7] QU, Qasim, Saudi Arabia
[8] King Abdulaziz Hosp, Jeddah, Saudi Arabia
[9] King Salman Hosp, Riyadh, Saudi Arabia
[10] King Fahad Hosp, Ibn Sina Coll, Jeddah, Saudi Arabia
[11] Majmaah Univ, Al Majmaah, Saudi Arabia
关键词
Prevalence; pulmonary hypertension; sickle cell anemiai patient; mortality; DISEASE; THALASSEMIA; MANAGEMENT;
D O I
10.9734/JPRI/2021/v33i37A32001
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Pulmonary hypertension (PH) is a relatively common and severe complication of SCI and an independent risk factor for mortality. Sickle cell disease is considered one of the most common diseases in the Kingdom of Saudi Arabia. When a healthy disease related to cardiovascular health is highlighted, sickle cell anemia may be the most common and related disease in high pulmonary pressure. In this study, we aimed to determine prevalence of PHTN in SCA patient, and associated risk factors with it. Methodology: This is an analytical cross-sectional study conducted in kingdom of Saudi Arabia (General population, SCA patient and CVD patient), from 29/7/2020 till 15/11/2020. The study was depending on online self-reported questionnaire that included assessing the demographic factors as gender, nationality besides, disease-related information: SCA patient, CVD patient and DM patient. Results: we received 794 responses to our questionnaire where 93.5% of them were Saudi Arabian. The prevalence of sickle cell anemia is 8.8%. Male represented 29.8% of patients while female represented 52.2% of patients. In SCA patients, the prevalence of PHTN was 31.8%. Moreover, it was found that having cardiac disease is considered a risk factor for developing PHTN where 37.7% of patients having cardiac disease had PHTN compared with 6.2% of health patients (OD: 9.16, 95% CI: 5.5479 to 15.13, P=0.000) while diabetes mellitus increase risk for developing PHTN by more than seven fold (OD: 7.6, 95% CI; 4.7175 to 12.4, P=0.000) and disorder of nervous system by 12 folds (OD: 12.7; 95% CI: 7.6658 to 21.09, P=0.000). Conclusion: we had found that the prevalence if SCA among Saudi Arabia is 8.8% with a higher prevalence in female than male. Moreover, the prevalence of PHTN in SCA patients was high about 31.8% which is much higher than its prevalence in normal individuals. Moreover, it was found that having cardiac disease is considered a risk factor for developing PHTN besides, having diabetic condition and disorder of nervous system which increased risk for developing PHTN in SCA by nine, seven and 12-fold respectively.
引用
收藏
页码:214 / 220
页数:7
相关论文
共 50 条
  • [1] Prevalence of Pulmonary Hypertension in patients with sickle cell disease
    Ranu, H.
    Lee, J.
    Brown, L.
    Rose, C.
    Buyck, H.
    Willis, F.
    Madden, B. P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [2] Prevalence of pulmonary hypertension in children with sickle cell disease
    Pashankar, F.
    Carbonella, J.
    Bazzy-Asaad, A.
    Friedman, A.
    PEDIATRIC BLOOD & CANCER, 2007, 48 (06) : 613 - 613
  • [3] Prevalence of Pulmonary Hypertension in Patients Hospitalized with Sickle Cell Crisis
    Gaddam, Mrunanjali
    Sinha, Samridhi
    Jayakumar, Jayalekshmi
    Iqbal, Rabia
    Kavuri, Swathi
    Hysenaj, Zhenisa
    Ramos, Ana Colon
    Atluri, Sobha
    Singh, Surbhi
    Quadri, Kalimullah
    Shulimovich, Maxim
    BLOOD, 2024, 144 : 2306 - 2307
  • [4] Prevalence of pulmonary hypertension (PHT) in sickle cell disease (SCD).
    Ataga, KI
    Kelly, EA
    Santucci, S
    Strayhorn, D
    Amamoo, AM
    Rodgers, G
    Orringer, EP
    BLOOD, 2002, 100 (11) : 451A - 451A
  • [5] High prevalence of pulmonary hypertension in children with sickle cell disease
    Nelson, Stephen C.
    Adade, Beverly B.
    McDonough, Elizabeth A.
    Moquist, Kristin L.
    Hennessy, Jane M.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2007, 29 (05) : 334 - 337
  • [7] Pulmonary hypertension and NO in sickle cell
    Gladwin, Mark T.
    Barst, Robyn J.
    Castro, Oswaldo L.
    Gordeuk, Victor R.
    Hillery, Cheryl A.
    Kato, Gregory J.
    Kim-Shapiro, Daniel B.
    Machado, Roberto
    Morris, Claudia R.
    Steinberg, Martin H.
    Vichinsky, Elliott P.
    BLOOD, 2010, 116 (05) : 852 - 854
  • [8] LOW PREVALENCE OF PULMONARY ARTERY HYPERTENSION IN CHILDREN WITH SICKLE CELL ANEMIA
    Kalpatthi, Ram
    Ngwube, Alexander
    Hlavacek, Anthony
    Bowman, Michael
    Jackson, Sherron
    Imran, Hamayun
    PEDIATRIC BLOOD & CANCER, 2009, 52 (06) : 725 - 725
  • [9] High Prevalence of Pulmonary Hypertension in Homozygous Sickle Cell Patients with Leg Ulceration
    Serarslan, Gamze
    Akgul, Ferit
    Babayigit, Cenk
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2009, 31 (01) : 44 - 48
  • [10] Prevalence of pulmonary hypertension (PHTN) in sickle cell disease (SCD) adolescents with pulmonary complications.
    Onyekwere, OC
    Campbell, A
    Williams, J
    Gaskin, P
    Rana, S
    Gordeuk, VR
    Castro, OL
    BLOOD, 2004, 104 (11) : 26B - 26B